Business
InMed Pharmaceuticals to Present at the Biotech Showcase Conference
InMed Pharmaceuticals to Present at the Biotech Showcase Conference Canada NewsWir...
About this update from Infield Minerals Corp
[{"type":"text","content":"\n\n\n\nInMed Pharmaceuticals to Present at the Biotech Showcase Conference\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nVANCOUVER, Jan. 8, 2020\n\n\n\nVANCOUVER, Jan. 8, 2020 /CNW/ - InMed Pharmaceuticals Inc. (\"InMed\" or \"the Company\") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet medical needs, today announced that Eric A. Adams, President & CEO will be presenting at the Biotech Showcase conference to be held at the Hilton San Francisco Union Square in San Francisco, California from January 13-15, 2020.\n\n \n \n\n \nMr. Adams will be presenting a corporate update on Tuesday, January 14 at 9:00 AM PT / 12:00 PM ET in the Yosemite C room. A live audio webcast of the presentation will be available at: https://event.webcasts.com/starthere.jsp?ei=1278532&tp_key=7010a4a8ba and through InMed's corporate website in the 'Investor' section at https://investors.inmedpharma.com.\nIn addition, any investors attending the conference that wish to meet with InMed's management for a one-on-one meeting can also contact Joseph Green at [email protected] or Laine Yonker at [email protected].\nAbout InMed:\nInMed Pharmaceuticals is a clinical stage biopharmaceutical company developing a proprietary biosynthesis platform for the manufacturing of pharmaceutical-grade cannabinoids, as well as a pipeline of cannabinoid-based medications that target diseases with high unmet medical needs.  The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based medicines.  For more information, visit www.inmedpharma.com.\nCautionary Note Regarding Forward-Looking Information:\nThis news release contains \"forward-looking information\" and \"forward-looking statements\" (collectively, \"forward-looking information\") within the meaning of applicable securities laws.  Forward-looking information is based on management's current expectations and beliefs and is subject to a number of risks and unc...